دورية أكاديمية

Efficacy and Safety of Neoadjuvant Chemoradiation Therapy Administered for 5 Versus 2 Weeks for Resectable and Borderline Resectable Pancreatic Cancer.

التفاصيل البيبلوغرافية
العنوان: Efficacy and Safety of Neoadjuvant Chemoradiation Therapy Administered for 5 Versus 2 Weeks for Resectable and Borderline Resectable Pancreatic Cancer.
المؤلفون: Suto, Hironobu, Okano, Keiichi, Oshima, Minoru, Ando, Yasuhisa, Matsukawa, Hiroyuki, Takahashi, Shigeo, Shibata, Toru, Kamada, Hideki, Kobara, Hideki, Tsuji, Akihito, Masaki, Tsutomu, Suzuki, Yasuyuki
المصدر: Pancreas; Mar2022, Vol. 51 Issue 3, p269-277, 9p
قاعدة البيانات: Complementary Index
الوصف
تدمد:08853177
DOI:10.1097/MPA.0000000000002011